Elevated concentrations of calprotectin are found in the plasma and synovial fluids of rheumatoid arthritis patients, and S100A9 is known to exacerbate chronic inflammation in models of arthritis [6, 24, 49, 50]. Here, S100A9 is linked to inflammatory response.